已收录 268921 条政策
 政策提纲
  • 暂无提纲
Predicting contrast induced nephropathy in patients undergoing percutaneous coronary intervention
[摘要] Contrast induced nephropathy (CIN) is an iatrogenic renal injury that occurs following the administration of intra-vascular radio-opaque contrast media. It affects 1–2% of all patients undergoing coronary angiography procedures and accounts for a third of all in-hospital acquired kidney injuries (1). As we are now performing coronary procedures more frequently in older patients with a multitude of comorbidities, CIN is becoming increasingly relevant. Furthermore, it is not an entirely benign event. Although, in the majority of patients, the renal impairment is transient, the development of CIN has also been associated with prolonged hospitalisation, increased cardiovascular events and increased mortality at short and medium term follow up (2-4). Therefore, the ability to prospectively identify those patients at risk and take appropriate precautionary measures including a reduction in contrast volume and administration of prophylactic treatment would be advantageous.
[发布日期]  [发布机构] 
[效力级别]  [学科分类] 呼吸医学
[关键词]  [时效性] 
   浏览次数:2      统一登录查看全文      激活码登录查看全文